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Résumé en
anglais
In recent years, Geosmithia argillacea has been increasingly reported in humans
and animals and can be considered an emerging pathogen. The taxonomy of
Geosmithia was recently studied, and Geosmithia argillacea and related species
were transferred to the new genus Rasamsonia. The diversity among a set of
Rasamsonia argillacea strains, including 28 clinical strains, was studied, and
antifungal susceptibility profiles were generated. Data obtained from morphological
studies and from phylogenetic analyses of internal transcribed spacer (ITS) and
partial β-tubulin and calmodulin sequences revealed the presence of four species in
the Rasamsonia argillacea complex, two of which are newly described here: R.
piperina sp. nov. and R. aegroticola sp. nov. In contrast to other related genera, all
Rasamsonia species can be identified with ITS sequences. A retrospective
identification was performed on recently reported clinical isolates from animal or
human patients. Susceptibility tests showed that the antifungal susceptibility
profiles of the four members of the R. argillacea complex are similar, and
caspofungin showed significant activity in vitro, followed by amphotericin B and
posaconazole. Voriconazole was the least active of the antifungals tested. The
phenotypically similar species R. brevistipitata and R. cylindrospora had different
antifungal susceptibility profiles, and this indicates that correct species
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